2024-10-01 2025-09-30 false Capium Accounts Production 1.1 10956646 2024-10-01 2025-09-30 10956646 bus:FullAccounts 2024-10-01 2025-09-30 10956646 bus:FRS102 2024-10-01 2025-09-30 10956646 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 10956646 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 10956646 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10956646 2024-10-01 2025-09-30 10956646 2025-09-30 10956646 bus:RegisteredOffice 2024-10-01 2025-09-30 10956646 core:WithinOneYear 2025-09-30 10956646 core:AfterOneYear 2025-09-30 10956646 1 2024-10-01 2025-09-30 10956646 bus:Director1 2024-10-01 2025-09-30 10956646 bus:Director1 2025-09-30 10956646 bus:Director1 2023-10-01 2024-09-30 10956646 bus:Director2 2024-10-01 2025-09-30 10956646 bus:Director2 2025-09-30 10956646 bus:Director2 2023-10-01 2024-09-30 10956646 2023-10-01 10956646 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 10956646 2023-10-01 2024-09-30 10956646 2024-09-30 10956646 core:WithinOneYear 2024-09-30 10956646 core:AfterOneYear 2024-09-30 10956646 bus:EntityAccountantsOrAuditors 2023-10-01 2024-09-30 10956646 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 10956646 bus:OrdinaryShareClass1 2025-09-30 10956646 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 10956646 bus:OrdinaryShareClass1 2024-09-30 10956646 core:ComputerEquipment 2024-10-01 2025-09-30 10956646 core:ComputerEquipment 2025-09-30 10956646 core:ComputerEquipment 2024-09-30 10956646 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-09-30 10956646 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 10956646 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 10956646 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 10956646 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 10956646 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 10956646 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 10956646 core:Non-currentFinancialInstruments 2025-09-30 10956646 core:Non-currentFinancialInstruments 2024-09-30 10956646 core:ShareCapital 2025-09-30 10956646 core:ShareCapital 2024-09-30 10956646 core:RetainedEarningsAccumulatedLosses 2025-09-30 10956646 core:RetainedEarningsAccumulatedLosses 2024-09-30 10956646 core:ShareCapitalOrdinaryShares 2024-10-01 10956646 core:ShareCapitalOrdinaryShares 2023-10-01 10956646 core:ShareCapitalOrdinaryShares 2024-10-01 2025-09-30 10956646 core:ShareCapitalOrdinaryShares 2023-10-01 2024-09-30 10956646 core:ShareCapitalOrdinaryShares 2025-09-30 10956646 core:ShareCapitalOrdinaryShares 2024-09-30 10956646 core:RetainedEarningsAccumulatedLosses 2024-10-01 10956646 core:RetainedEarningsAccumulatedLosses 2023-10-01 10956646 core:RetainedEarningsAccumulatedLosses 2024-10-01 2025-09-30 10956646 core:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 10956646 core:RetainedEarningsAccumulatedLosses 2025-09-30 10956646 core:RetainedEarningsAccumulatedLosses 2024-09-30 10956646 dpl:Item1 2024-10-01 10956646 dpl:Item1 2025-09-30 10956646 dpl:Item1 2023-10-01 10956646 dpl:Item1 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10956646
England and Wales

 

 

 

PRESSMAN HEALTH LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 01 October 2024

End date: 30 September 2025
Directors Lena Louise Walliman
Anton Paul Walliman
Registered Number 10956646
Registered Office Mill House
The Fence
St Briavels
Lydney
GL15 6QG
Accountants Child and Child Accountants Ltd
49 Somerset Street
Abertillery
Gwent
NP13 1DL
1
Director's report and financial statements
The directors present his/her/their annual report and the financial statements for the year ended 30 September 2025.
Principal activities
Principal activity of the company during the financial year was of Consultancy.
Directors
The directors who served the company throughout the year were as follows:
Lena Louise Walliman
Anton Paul Walliman
Statement of directors' responsibilities
The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

This report was approved by the board and signed on its behalf by:


----------------------------------
Anton Paul Walliman
Director

Date approved: 22 April 2026
2
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of PRESSMAN HEALTH LIMITED for the year ended 30 September 2025.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of PRESSMAN HEALTH LIMITED for the year ended 30 September 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance.
This report is made solely to the Board of Directors of PRESSMAN HEALTH LIMITED , as a body, in accordance with the terms of our engagement letter dated 22 April 2026. Our work has been undertaken solely to prepare for your approval the accounts of PRESSMAN HEALTH LIMITED and state those matters that we have agreed to state to the Board of Directors of PRESSMAN HEALTH LIMITED , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than PRESSMAN HEALTH LIMITED and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that PRESSMAN HEALTH LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of PRESSMAN HEALTH LIMITED . You consider that PRESSMAN HEALTH LIMITED is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of PRESSMAN HEALTH LIMITED . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts

30 September 2025.



....................................................
Child and Child Accountants Ltd
49 Somerset Street
Abertillery
Gwent
NP13 1DL
22 April 2026
3
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 4 13,987    4,949 
13,987    4,949 
Current assets      
Stocks 5 9,041   
Debtors 6 76,184    88,168 
Cash at bank and in hand 50,633    24,670 
135,858    112,838 
Creditors: amount falling due within one year 7 (149,587)   (83,167)
Net current assets (13,729)   29,671 
 
Total assets less current liabilities 258    34,620 
Net assets 258    34,620 
 

Capital and reserves
     
Called up share capital 8 100    100 
Profit and loss account 158    34,520 
Shareholders' funds 258    34,620 
 


For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 22 April 2026 and were signed on its behalf by:


-------------------------------
Anton Paul Walliman
Director
4
  Equity share capital   Retained Earnings   Total
£ £ £
At 01 October 2023 100  (3,539) (3,439)
Profit for the year 131,559  131,559 
Total comprehensive income for the year 131,559  131,559 
Dividends (93,500) (93,500)
Total investments by and distributions to owners (93,500) (93,500)
At 30 September 2024 100  34,520  34,620 
At 01 October 2024 100  34,520  34,620 
Profit for the year 94,338  94,338 
Total comprehensive income for the year 94,338  94,338 
Dividends (128,700) (128,700)
Total investments by and distributions to owners (128,700) (128,700)
At 30 September 2025 100  158  258 
5
General Information
PRESSMAN HEALTH LIMITED is a private company, limited by shares, registered in England and Wales, registration number 10956646, registration address Mill House, The Fence, St Briavels, Lydney, GL15 6QG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the balance sheet when their payment has been approved by the shareholders prior to the balance sheet date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and machinery etc 25%
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2.

Staff Costs

2025
£
  2024
£
Wages and salaries 115,739   
Social security costs 2,698   
Pension costs, defined contribution plan 1,230   
Other staff costs 3,750   
123,417   
 
Average number of employees during the year Number   Number
Administration 6   
 

3.

Average number of employees

Average number of employees during the year was 6 (2024 : 0).
4.

Tangible fixed assets

Cost or valuation Plant and machinery etc   Total
  £   £
At 01 October 2024 14,065    14,065 
Additions 11,533    11,533 
Disposals  
At 30 September 2025 25,598    25,598 
Depreciation
At 01 October 2024 9,118    9,118 
Charge for year 2,493    2,493 
On disposals  
At 30 September 2025 11,611    11,611 
Net book values
Closing balance as at 30 September 2025 13,987    13,987 
Opening balance as at 01 October 2024 4,949    4,949 


5.

Stocks

2025
£
  2024
£
Work in Progress 9,041   
9,041   

6.

Debtors: amounts falling due within one year

2025
£
  2024
£
Trade Debtors 65,685    88,168 
Directors' Current Accounts 10,499   
76,184    88,168 

7.

Creditors: amount falling due within one year

2025
£
  2024
£
Bank Loans 2,819    6,223 
Corporation Tax 53,329    42,808 
PAYE & Social Security 4,463   
Accruals 1,784   
Other Creditors 58,152    1,701 
Pension Creditor (65)  
Net wages creditor (332)  
Directors' Current Accounts   264 
VAT 29,437    32,171 
149,587    83,167 

8.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

6